Task: Answer the multiple-choice question.
Question: Which drug has a 1.512% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
[a] O=C(CCn1c(=S)oc2ccccc21)NCCC1=CCCCC1
[b] CCC(C(=O)NC1CCCC1)N(C(=O)c1snc(C(N)=O)c1N)c1ccc(OC)c(OC)c1
Answer: a. O=C(CCn1c(=S)oc2ccccc21)NCCC1=CCCCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(CCn1c(=S)oc2ccccc21)NCCC1=CCCCC1
O=C(CCn1c(=S)oc2ccccc21)NCCC1=CCCCC1
N-[2-(cyclohexen-1-yl)ethyl]-3-(2-sulfanylidene-1,3-benzoxazol-3-yl)propanamide